A consensus-beating FY25 result from Fisher & Paykel Healthcare was undermined by disappointing FY26 guidance, with tariffs partly to blame
As if all was forgiven from April, in May the ASX joined the rally in US and European equities boosted by technology and the AI trade
Despite a slight miss against FY25 earnings guidance expectations, Goodman Group’s third quarter operational update signaled growth ahead
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Management outlined a vision for FY30 and beyond at Telstra’s investor Day, including a target of sustainable, growing dividends over the coming five years
Its largest acquisition ever should transform WiseTech Global into the global trade powerhouse its founder wants it to be
Wesfarmers’ strategy day highlighted further growth opportunities including a doubling in size of Kmart and Anko going international
Light & Wonder paints a picture for investors by setting aggressive targets out to FY28, to the general approval of analysts